Our Pricing

Boots Wegovy: UK Price Comparison & Prescription Access

Published: 10 September 2026

Many patients searching for boots wegovy are exploring where to access this prescription weight loss injection in the UK at competitive prices. Wegovy (semaglutide 2.4mg) is a once-weekly GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities [1]. At Cured Pharmacy, Wegovy is available from £69.00 following a free online consultation with our UK-registered prescribers, offering transparent pricing and discreet home delivery.

What Is Boots Wegovy and How Does It Work?

When patients ask about boots wegovy, they're typically referring to Wegovy (semaglutide) injection, a prescription-only weight loss medication available through UK pharmacies. Wegovy works by mimicking GLP-1, a naturally occurring hormone that regulates appetite and food intake by acting on receptors in the brain to reduce hunger and increase feelings of fullness [1]. This mechanism helps patients achieve sustainable weight loss when combined with a reduced-calorie diet and increased physical activity.

Clinical trials demonstrated that Wegovy users lost an average of 15% of their body weight over 68 weeks, significantly more than placebo groups [2]. The medication is administered as a subcutaneous injection once weekly, with doses gradually increased from 0.25mg to a maintenance dose of 2.4mg over 16-20 weeks. This titration schedule minimises gastrointestinal side effects whilst allowing the body to adjust to the medication. All Wegovy prescriptions require assessment by a UK-registered prescriber to confirm suitability based on BMI, medical history, and contraindications.

Boots Wegovy Price Comparison Across UK Pharmacies

Price transparency is essential when comparing boots wegovy costs across different UK providers. At Cured Pharmacy, Wegovy injections start from £69.00 per pen, with prices clearly displayed before you begin your consultation. This upfront pricing model ensures no hidden fees or unexpected charges, and new patients receive £20 off their first order using code Weightlossnew.

Whilst major high-street pharmacy chains stock Wegovy, pricing structures can vary considerably depending on dosage strength and supply agreements. Online registered pharmacies like Cured Pharmacy often provide more competitive rates due to lower operational overheads, passing savings directly to patients. Our GPhC-registered service (9012511) combines affordability with clinical safety, ensuring every prescription is reviewed by qualified UK prescribers including our superintendent pharmacist Tarun Kumar (GPhC 2233073).

Understanding Wegovy Prescription Costs

The total cost of boots wegovy treatment depends on your prescribed dosage and treatment duration. Most patients remain on the 2.4mg maintenance dose long-term to sustain weight loss results. At Cured Pharmacy, our pricing structure reflects the actual cost per pen rather than inflated per-month estimates, giving you complete clarity on what you'll pay. All prices include the clinical consultation, prescription review, and discreet home delivery across the UK.

How to Access Boots Wegovy Through Cured Pharmacy

Accessing boots wegovy alternatives through Cured Pharmacy is straightforward and completed entirely online. Begin by completing our free medical consultation questionnaire, which takes under three minutes and covers your weight loss goals, medical history, current medications, and any contraindications. Our UK-registered prescribers review every submission individually to determine whether Wegovy is clinically appropriate for you [3].

If approved, your prescription is issued electronically and dispensed by our GPhC-registered pharmacy team. Wegovy is then dispatched in 100% discreet packaging with next-day delivery options available across the UK. Should Wegovy not be suitable, our prescribers may recommend alternative treatments such as Mounjaro (tirzepatide), Saxenda (liraglutide), or oral weight loss medications depending on your clinical profile and preferences.

Eligibility Criteria for Wegovy Prescriptions

To be prescribed boots wegovy or its equivalents, UK clinical guidelines require a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidaemia [4]. Patients must also demonstrate commitment to lifestyle modifications including dietary changes and increased physical activity. Wegovy is contraindicated in pregnancy, breastfeeding, personal or family history of medullary thyroid carcinoma, and multiple endocrine neoplasia syndrome type 2.

Boots Wegovy Side Effects and Safety Considerations

Understanding potential side effects is crucial when starting boots wegovy or any GLP-1 medication. The most common adverse effects are gastrointestinal, including nausea (44% of patients), diarrhoea (30%), vomiting (24%), and constipation (24%) during clinical trials [2]. These symptoms typically occur during dose escalation and diminish as the body adjusts to the medication. Taking Wegovy with food and staying well-hydrated can help manage these effects.

Serious but rare side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking diabetes medications concurrently). Patients should seek immediate medical attention if experiencing severe abdominal pain, persistent vomiting, or signs of allergic reaction. Our clinical team provides comprehensive safety information during your consultation and remains available for follow-up questions throughout your treatment journey. Regular monitoring and dose adjustments ensure boots wegovy is used safely and effectively.

Boots Wegovy vs Alternative Weight Loss Treatments

Patients researching boots wegovy often want to understand how it compares to other prescription weight loss options available in the UK. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that demonstrated even greater weight loss in head-to-head trials, with patients losing an average of 22.5% body weight versus 15% with semaglutide [5]. However, Mounjaro starts from £69.00 at Cured Pharmacy, making Wegovy a more accessible option for many patients.

Saxenda (liraglutide 3mg) is another GLP-1 injection requiring daily administration rather than weekly, priced from £69.00. For patients preferring oral medications, Wegovy® Oral Tablets (semaglutide pill) offer the same active ingredient in tablet form from £69.00, whilst Orlistat-based treatments like Xenical provide a non-GLP-1 mechanism targeting fat absorption from £69.00. Your prescriber will discuss which boots wegovy alternative best suits your medical profile, lifestyle preferences, and budget during consultation.

Choosing Between Injection and Oral Weight Loss Medications

The choice between boots wegovy injections and oral alternatives depends on individual preferences and clinical factors. Weekly injections offer convenience and consistent drug levels, whilst daily tablets may suit patients with needle aversion. GLP-1 medications like Wegovy and Mounjaro generally produce greater weight loss than Orlistat-based treatments but carry different side effect profiles [6]. Our prescribers provide personalised recommendations based on your complete medical assessment.

Long-Term Results and Maintenance with Boots Wegovy

Sustaining weight loss achieved with boots wegovy requires ongoing treatment and lifestyle commitment. The STEP clinical trial programme followed patients for up to 104 weeks, demonstrating that weight loss plateaus around 60-68 weeks and is maintained with continued semaglutide use [7]. Discontinuation studies showed that patients regained approximately two-thirds of lost weight within one year of stopping treatment, highlighting the chronic nature of obesity management.

At Cured Pharmacy, we support long-term weight management through ongoing prescription renewals, clinical monitoring, and lifestyle guidance. Our UK prescribers review your progress regularly and adjust treatment as needed to optimise results whilst minimising side effects. Combining boots wegovy with sustainable dietary changes, regular physical activity, and behavioural modifications provides the best outcomes for lasting weight control. Transparent pricing from £69.00 per pen makes continued treatment accessible without compromising on clinical quality or safety.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 10 September 2026]
2. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 10 September 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. [accessed 10 September 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. [accessed 10 September 2026]
5. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 10 September 2026]
6. Khera, R., Murad, M. H., Chandar, A. K., et al. (2016). Association of pharmacological treatments for obesity with weight loss and adverse events: A systematic review and meta-analysis. JAMA, 315(22), 2424-2434. [accessed 10 September 2026]
7. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: The STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 10 September 2026]
8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 10 September 2026.
9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 10 September 2026.
10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 10 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.